For earlier disease detection in primary care, the “best” AI screening providers usually depend on which disease area you want to screen for, because primary care screening is highly use-case-specific. That said, the strongest providers today tend to be in a few categories:

1) Cardiometabolic / cardiovascular risk

These tools help identify patients at risk for heart disease, stroke, diabetes, or kidney disease earlier from routine EHR data, labs, vitals, and demographics.

Notable providers

• Qure.ai / qXR, qER – More widely known for imaging, but relevant where chest imaging is used in primary care or urgent care workflows.
• Cleerly – More advanced cardiac imaging/risk stratification; usually not pure primary care screening, but useful for earlier detection pathways.
• Twill (formerly Happify Health, includes some risk-management tools) – More population-health oriented, though not a classic “screening AI” vendor.
• Innovaccer – Strong in primary-care population health analytics and risk stratification; often used to surface high-risk patients.

2) Diabetes and metabolic disease risk prediction

These solutions flag patients at risk before diagnosis, often using EHR data.

Notable providers

• IBM Watson Health / Merative analytics assets – Historically strong in risk analytics, though market positioning has evolved.
• Innovaccer
• Health Catalyst
• Veradigm These are more “predictive analytics” than standalone screening apps, but they’re commonly used in primary care settings.

3) Eye disease / diabetic retinopathy screening

This is one of the most mature AI screening categories and is highly compatible with primary care.

Notable providers

• IDx-DR (Digital Diagnostics) – One of the best-known autonomous AI systems for diabetic retinopathy detection.
• EyeArt (Eyenuk) – Strong presence in screening workflows for diabetic eye disease.
• AEYE Health – Portable/autonomous retinal screening options.
• Retinal screening platforms from Topcon / Canon / Haag-Streit partners – Often integrated AI rather than pure AI vendor.

4) Lung disease / chest X-ray screening

Useful where primary care uses chest X-ray referral pathways.

Notable providers

• Qure.ai
• Lunit
• Aidence (Siemens Healthineers)
• Annalise.ai These are among the most established AI imaging screening vendors, especially for incidental findings and earlier detection of lung abnormalities.

5) Bone health / osteoporosis risk

Less mature, but useful for proactive screening.

Notable providers

• OsteoSight
• Visiana
  Often more imaging-centered than general primary care tools.

6) Dermatology / skin cancer triage

Can support primary care triage and referral prioritization.

Notable providers

• SkinVision
• DermaSensor These tools are more about triage and risk assessment than definitive diagnosis.

---

If you want the most practical “best-in-class” options for primary care today

I’d shortlist by use case:

• Diabetic retinopathy screening: Digital Diagnostics (IDx-DR), Eyenuk
• Chest X-ray / pulmonary screening: Qure.ai, Lunit, Annalise.ai
• Population risk stratification from EHRs: Innovaccer, Health Catalyst, Veradigm
• Skin lesion triage: DermaSensor, SkinVision

---

What to evaluate before buying

For primary care, the most important criteria are:

1. Clinical validation

   • Prospective studies
   • Real-world performance in primary care, not just specialist settings

2. Regulatory status

   • FDA clearance / CE marking / other local approvals
   • Whether it’s autonomous or decision-support only

3. Workflow fit

   • Can it fit into EHR/EMR?
   • Does it add clinician burden?
   • Can staff use it at point of care?

4. Reimbursement

   • Is there a billable pathway?
   • Does it support value-based care or population health incentives?

5. Fairness and generalizability

   • Performance across age, sex, ethnicity, and comorbidity groups

6. Actionability

   • Does it lead to referrals, treatment, or follow-up, not just alerts?

---

Bottom line

If your goal is earlier detection in primary care, the most mature and clinically actionable AI screening vendors are typically:

• Digital Diagnostics (IDx-DR) for diabetic retinopathy
• Eyenuk
• Qure.ai
• Lunit
• Annalise.ai
• Innovaccer for broader primary-care risk stratification

If you want, I can also give you:

1. a ranked vendor comparison table,
2. recommendations by specific disease area, or
3. a shortlist optimized for US primary care vs UK/EU vs global markets.